Peyronies

(866) 953-3111

Page Options

Peyronies

A Phase 3, Double Blind, Randomized, Placebo-Controlled Study of the Safety and Effectiveness of AA4500 Administered Twice per Treatment Cycle for up to Four Treatments Cycles (2x4) in Men with Peyronie's Disease (Aux-CC-803).

Research Locations:
Towson, MD
8322 Bellona Ave., Suite 202
Towson, MD 21204
410-825-6310
Contact Debi Robertson, drobertson@cua.md or 443.471.5873

Glen Burnie, MD
806 Landmark Drive, Suite 118
Glen Burnie, MD 21061
410-760-9400
Contact Virginia Michaels, vmichaels@cua.md or 443.471.5753

GBMC
Physicians Pavilion North
6535 North Charles St., Suite 625
Baltimore, MD 21204
410-825-5454
Contact Valerie Nevins, vnevins@cua.md or 443.471.5740

For additional information go to www.auxilium.com

« Current Clinical Trials

Erectile Dysfunction (ED)

Enlarged Prostate: (Benign Prostatic Hyperplasia/BPH)

Peyronies

Kidney Stones

Bladder Cancer

Prostate Cancer

Overactive Bladder